menu
    • menu

    Company profile for Boston Pharmaceuticals

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We acquire drug development programs as early as the start of IND-enabling studies Boston Pharmaceuticals leverages a highly experienced drug development team to generate clinical data to create value for our organization and our partners. We have rapidly built a portfolio of high-value candidates across multiple therapeutic areas and are actively seeking additional programs for our diverse pipeline.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Boston PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    55 Cambridge Parkway Suite 400 Cambridge, MA 02142
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.bostonpharmaceuticals.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    GSK to buy liver disease drug for up to $2 billion
    GSK to buy liver disease drug for up to $2 billion

    15 May 2025

    // PRESS RELEASE

    https://www.gsk.com/en-gb/media/press-releases/gsk-to-acquire-efimosfermin-a-phase-iii-ready-potential-best-in-class-specialty-medicine-to-treat-and-prevent-progression-of-steatotic-liver-disease-sld/

    PRESS RELEASE
    15 May 2025
    Share Share
    Boston to Present Efimosfermin Data in F2/F3 MASH at EASL Meeting
    Boston to Present Efimosfermin Data in F2/F3 MASH at EASL Meeting

    28 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250428674777/en/Boston-Pharmaceuticals-to-Present-the-Effect-of-Efimosfermin-Alfa-on-Collagen-Biomarkers-in-Patients-with-F2-and-F3-MASH-at-EASL-Congress-2025

    BUSINESSWIRE
    28 Apr 2025
    Share Share
    Boston Pharma to Present Efimosfermin Alfa at DDW 2025
    Boston Pharma to Present Efimosfermin Alfa at DDW 2025

    23 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250423472313/en/Boston-Pharmaceuticals-to-Present-State-of-the-Art-Lecture-and-Poster-for-Once-monthly-Efimosfermin-Alfa-at-Digestive-Disease-Week-2025

    BUSINESSWIRE
    23 Apr 2025
    Share Share
    Boston Pharma to Present Positive Phase 2 Data on BOS-580 in MASH
    Boston Pharma to Present Positive Phase 2 Data on BOS-580 in MASH

    15 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241115839453/en

    BUSINESSWIRE
    15 Nov 2024
    Share Share
    Boston Pharma To Present Phase 2 Results At AASLD Liver Meeting®
    Boston Pharma To Present Phase 2 Results At AASLD Liver Meeting®

    16 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241016942643/en

    BUSINESSWIRE
    16 Oct 2024
    Share Share
    Boston Pharmaceuticals Appoints Dr. Margaret Koziel as New Chief Medical Officer
    Boston Pharmaceuticals Appoints Dr. Margaret Koziel as New Chief Medical Officer

    06 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240606886033/en

    BUSINESSWIRE
    06 Jun 2024
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search